KENNETH COX: Open Payments
NPI 1730158809 · DOTHAN, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$534 in 30 payments from 10 companies in 2025. Trend: 2023 $288 · 2024 $354 · 2025 $534
Food & beverage: $534
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 12 | $169 |
| AstraZeneca Pharmaceuticals LP | 7 | $135 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $72 |
| Axsome Therapeutics, Inc. | 2 | $41 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $26 |
| ABBVIE INC. | 1 | $24 |
| SHIELD THERAPEUTICS INC | 1 | $21 |
| Exact Sciences Corporation | 1 | $17 |
| Kowa Pharmaceuticals America, Inc. | 1 | $15 |
| Novo Nordisk Inc | 1 | $15 |
Products named: MOUNJARO, Kerendia, FARXIGA, BREZTRI, Auvelity, JARDIANCE, CAPLYTA, QULIPTA.
Industry payments across AL — which companies pay providers there.
